AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
DOSE-INTENSIVE NEOADJUVANT CHEMOTHERAPY WITH GM-CSF IN LOCALLY ADVANCED BREAST-CANCER (LABC) - A CHEMO-IMMUNOTHERAPEUTIC APPROACH
Authors: HONKOOP AH HOEKMAN K VANGROENINGEN CJ VANDERWALL E WAGSTAFF J PINEDO HM
Citation: Ah. Honkoop et al., DOSE-INTENSIVE NEOADJUVANT CHEMOTHERAPY WITH GM-CSF IN LOCALLY ADVANCED BREAST-CANCER (LABC) - A CHEMO-IMMUNOTHERAPEUTIC APPROACH, European journal of cancer, 34, 1998, pp. 23-23
PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS
Authors: BOWMAN A TWELVES C HOEKMAN K SIMPSON A SMYTH J VERMORKEN J HOPPENER F BEIJNEN J VEGA E JIMENO J HANAUSKE AR
Citation: A. Bowman et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS, Annals of oncology, 9, 1998, pp. 452-452
PHARMACOKINETICS OF ECTEINASCIDIN-743 (ET-743) IN 3 PHASE-I STUDIES
Authors: HILLEBRAND MJX JIMENO J CVITKOVIC E HOEKMAN K HOPPENER F TWELVES C VILLALONA M ROSING H BEIJNEN JH
Citation: Mjx. Hillebrand et al., PHARMACOKINETICS OF ECTEINASCIDIN-743 (ET-743) IN 3 PHASE-I STUDIES, Annals of oncology, 9, 1998, pp. 455-455
5-FLUOROURACIL LEUCOVORIN-INDUCED INHIBITION OF THYMIDYLATE SYNTHASE IN NORMAL-TISSUES OF MOUSE AND MAN (VOL 123, PG 595, 1997)/
Authors: VANDERWILT CL VANGROENINGEN CJ PINEDO HM SMID K HOEKMAN K MEIJER S PETERS GJ
Citation: Cl. Vanderwilt et al., 5-FLUOROURACIL LEUCOVORIN-INDUCED INHIBITION OF THYMIDYLATE SYNTHASE IN NORMAL-TISSUES OF MOUSE AND MAN (VOL 123, PG 595, 1997)/, Journal of cancer research and clinical oncology, 124(2), 1998, pp. 130-130
PROGNOSTIC ROLE OF CLINICAL, PATHOLOGICAL AND BIOLOGICAL CHARACTERISTICS IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER
Authors: HONKOOP AH VANDIEST PJ DEJONG JS LINN SC GIACCONE G HOEKMAN K WAGSTAFF J PINEDO HM
Citation: Ah. Honkoop et al., PROGNOSTIC ROLE OF CLINICAL, PATHOLOGICAL AND BIOLOGICAL CHARACTERISTICS IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, British Journal of Cancer, 77(4), 1998, pp. 621-626
A PATIENT WITH ADRENOCORTICAL CARCINOMA - CHARACTERIZATION OF ITS BIOLOGICAL-ACTIVITY AND DRUG-RESISTANCE PROFILE
Authors: FELLER N HOEKMAN K KUIPER CM LINN SC VERHEUL HMW WOLTHERS BG POPPSNIJDERS C PINEDO HM
Citation: N. Feller et al., A PATIENT WITH ADRENOCORTICAL CARCINOMA - CHARACTERIZATION OF ITS BIOLOGICAL-ACTIVITY AND DRUG-RESISTANCE PROFILE, Clinical cancer research, 3(3), 1997, pp. 389-394
PLATELET - TRANSPORTER OF VASCULAR ENDOTHELIAL GROWTH-FACTOR
Authors: VERHEUL HMW HOEKMAN K BAKKER SLD EEKMAN CA FOLMAN CC BROXTERMAN HJ PINEDO HM
Citation: Hmw. Verheul et al., PLATELET - TRANSPORTER OF VASCULAR ENDOTHELIAL GROWTH-FACTOR, Clinical cancer research, 3(12), 1997, pp. 2187-2190
EXPERIENCE WITH INTRAPERITONEAL CISPLATIN AND ETOPOSIDE AND IV SODIUMTHIOSULFATE PROTECTION IN OVARIAN-CANCER PATIENTS WITH EITHER PATHOLOGICALLY COMPLETE RESPONSE OR MINIMAL RESIDUAL DISEASE
Authors: VANRIJSWIJK REN HOEKMAN K BURGER CW VERHEIJEN RHM VERMORKEN JB
Citation: Ren. Vanrijswijk et al., EXPERIENCE WITH INTRAPERITONEAL CISPLATIN AND ETOPOSIDE AND IV SODIUMTHIOSULFATE PROTECTION IN OVARIAN-CANCER PATIENTS WITH EITHER PATHOLOGICALLY COMPLETE RESPONSE OR MINIMAL RESIDUAL DISEASE, Annals of oncology, 8(12), 1997, pp. 1235-1241
MULTIPLE CYCLES OF HIGH-DOSE DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HONKOOP AH VANDERWALL E FELLER N SCHUURHUIS GJ VANDERVIJGH WJF BOVEN E VANGROENINGEN CJ GIACCONE G HOEKMAN K VERMORKEN JB WAGSTAFF J PINEDO HM
Citation: Ah. Honkoop et al., MULTIPLE CYCLES OF HIGH-DOSE DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 8(10), 1997, pp. 957-962
5-FLUOROURACIL LEUCOVORIN-INDUCED INHIBITION OF THYMIDYLATE SYNTHASE IN NORMAL-TISSUES OF MOUSE AND MAN/
Authors: VANDERWILT CL VANGROENINGEN CJ PINEDO HM SMID K HOEKMAN K MEIJER S PETERS GJ
Citation: Cl. Vanderwilt et al., 5-FLUOROURACIL LEUCOVORIN-INDUCED INHIBITION OF THYMIDYLATE SYNTHASE IN NORMAL-TISSUES OF MOUSE AND MAN/, Journal of cancer research and clinical oncology, 123(11-12), 1997, pp. 595-601
EXPRESSION OF DRUG-RESISTANCE PROTEINS IN BREAST-CANCER, IN RELATION TO CHEMOTHERAPY
Authors: LINN SC PINEDO HM VANARKOTTE J VANDERVALK P HOEKMAN K HONKOOP AH VERMORKEN JB GIACCONE G
Citation: Sc. Linn et al., EXPRESSION OF DRUG-RESISTANCE PROTEINS IN BREAST-CANCER, IN RELATION TO CHEMOTHERAPY, International journal of cancer, 71(5), 1997, pp. 787-795
HIGHLY SENSITIVE AND SPECIFIC DETECTION OF P-GLYCOPROTEIN FUNCTION FOR HEMATOLOGICAL AND SOLID TUMOR-CELLS USING A NOVEL NUCLEIC-ACID STAIN
Authors: BROXTERMAN HJ SCHUURHUIS GJ LANKELMA J OBERINK JW EEKMAN CA CLAESSEN AME HOEKMAN K POOT M PINEDO HM
Citation: Hj. Broxterman et al., HIGHLY SENSITIVE AND SPECIFIC DETECTION OF P-GLYCOPROTEIN FUNCTION FOR HEMATOLOGICAL AND SOLID TUMOR-CELLS USING A NOVEL NUCLEIC-ACID STAIN, British Journal of Cancer, 76(8), 1997, pp. 1029-1034
EFFECTS OF CHEMOTHERAPY ON PATHOLOGICAL AND BIOLOGIC CHARACTERISTICS OF LOCALLY ADVANCED BREAST-CANCER
Authors: HONKOOP AH PINEDO HM DEJONG JS VERHEUL HMW LINN SC HOEKMAN K WAGSTAFF J VANDIEST PJ
Citation: Ah. Honkoop et al., EFFECTS OF CHEMOTHERAPY ON PATHOLOGICAL AND BIOLOGIC CHARACTERISTICS OF LOCALLY ADVANCED BREAST-CANCER, American journal of clinical pathology, 107(2), 1997, pp. 211-218
WELL-DIFFERENTIATED PAPILLARY MESOTHELIOMA OF THE PERITONEUM - A SEPARATE ENTITY
Authors: HOEKMAN K TOGNON G RISSE EKJ BLOEMSMA CA VERMORKEN JB
Citation: K. Hoekman et al., WELL-DIFFERENTIATED PAPILLARY MESOTHELIOMA OF THE PERITONEUM - A SEPARATE ENTITY, European journal of cancer, 32A(2), 1996, pp. 255-258
DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN, CYCLOPHOSPHAMIDE AND GM-CSF FAILS TO IMPROVE SURVIVAL OF METASTATIC BREAST-CANCER PATIENTS
Authors: HONKOOP AH HOEKMAN K WAGSTAFF J BOVEN E VANGROENINGEN CJ GIACCONE G VERMORKEN JB PINEDO HM
Citation: Ah. Honkoop et al., DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN, CYCLOPHOSPHAMIDE AND GM-CSF FAILS TO IMPROVE SURVIVAL OF METASTATIC BREAST-CANCER PATIENTS, Annals of oncology, 7(1), 1996, pp. 35-39
INCIDENCE AND PREVENTION OF NONHEMATOLOGICAL TOXICITY OF HIGH-DOSE CHEMOTHERAPY
Authors: HOEKMAN K VERMORKEN JB
Citation: K. Hoekman et Jb. Vermorken, INCIDENCE AND PREVENTION OF NONHEMATOLOGICAL TOXICITY OF HIGH-DOSE CHEMOTHERAPY, Annals of medicine, 28(2), 1996, pp. 175-182
THE ROLE OF NITRIC-OXIDE IN BACTERIAL-MENINGITIS IN CHILDREN
Authors: KORNELISSE RF HOEKMAN K VISSER JJ HOP WCJ HUIJMANS JGM VANDERSTRAATEN PJC VANDERHEIJDEN AJ SUKHAI RN NEIJENS HJ DEGROOT R
Citation: Rf. Kornelisse et al., THE ROLE OF NITRIC-OXIDE IN BACTERIAL-MENINGITIS IN CHILDREN, The Journal of infectious diseases, 174(1), 1996, pp. 120-126
IL-1-BETA DOES NOT CAUSE NEUTROPHIL DEGRANULATION BUT DOES LEAD TO IL-6, IL-8, AND NITRITE NITRATE RELEASE WHEN USED IN PATIENTS WITH CANCER/
Authors: OGILVIE AC HACK CE WAGSTAFF J VANMIERLO GJ EERENBERG AJM THOMSEN LL HOEKMAN K RANKIN EM
Citation: Ac. Ogilvie et al., IL-1-BETA DOES NOT CAUSE NEUTROPHIL DEGRANULATION BUT DOES LEAD TO IL-6, IL-8, AND NITRITE NITRATE RELEASE WHEN USED IN PATIENTS WITH CANCER/, The Journal of immunology, 156(1), 1996, pp. 389-394
CONTINUOUS-INFUSION OR SUBCUTANEOUS INJECTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - INCREASED EFFICACY AND REDUCED TOXICITYWHEN GIVEN SUBCUTANEOUSLY
Authors: HONKOOP AH HOEKMAN K WAGSTAFF J VANGROENINGEN CJ VERMORKEN JB BOVEN E PINEDO HM
Citation: Ah. Honkoop et al., CONTINUOUS-INFUSION OR SUBCUTANEOUS INJECTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - INCREASED EFFICACY AND REDUCED TOXICITYWHEN GIVEN SUBCUTANEOUSLY, British Journal of Cancer, 74(7), 1996, pp. 1132-1136
P53 AND P-GLYCOPROTEIN ARE OFTEN COEXPRESSED AND ARE ASSOCIATED WITH POOR-PROGNOSIS IN BREAST-CANCER
Authors: LINN SC HONKOOP AH HOEKMAN K VANDERVALK P PINEDO HM GIACCONE G
Citation: Sc. Linn et al., P53 AND P-GLYCOPROTEIN ARE OFTEN COEXPRESSED AND ARE ASSOCIATED WITH POOR-PROGNOSIS IN BREAST-CANCER, British Journal of Cancer, 74(1), 1996, pp. 63-68
CLINICAL (WHO) AND SERUM TUMOR-MARKER (CA125) RESPONSE TO PLATINUM-BASED CHEMOTHERAPY AFTER TREATMENT WITH PACLITAXEL IN PATIENTS WITH OVARIAN-CANCER (OVCA)
Authors: VERMORKEN JB HUIJSKES RVHP HOEKMAN K BURGER CW VERHEIJEN RHM HEITBRINK MA PINEDO HM
Citation: Jb. Vermorken et al., CLINICAL (WHO) AND SERUM TUMOR-MARKER (CA125) RESPONSE TO PLATINUM-BASED CHEMOTHERAPY AFTER TREATMENT WITH PACLITAXEL IN PATIENTS WITH OVARIAN-CANCER (OVCA), European journal of cancer, 31A, 1995, pp. 517-517
RENAL-CELL CARCINOMA AND INTERLEUKIN-2 - A REVIEW
Authors: WAGSTAFF J BAARS JW WOLBINK GJ HOEKMAN K EERENBERGBELMER AJM HACK CE
Citation: J. Wagstaff et al., RENAL-CELL CARCINOMA AND INTERLEUKIN-2 - A REVIEW, European journal of cancer, 31A(3), 1995, pp. 401-408
HYPOTENSION INDUCED BY INTERLEUKIN-3 IN PATIENTS ON ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
Authors: DERCKSEN MW HOEKMAN K VISSER JJ HUININK WWT PINEDO HM WAGSTAFF J
Citation: Mw. Dercksen et al., HYPOTENSION INDUCED BY INTERLEUKIN-3 IN PATIENTS ON ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, Lancet, 345(8947), 1995, pp. 448-448
TUMOR-INDUCED HYPOGLYCEMIA - A CASE-REPORT
Authors: HOEKMAN K VANDOORN J GLOUDEMANS T HOEKSTRA OS MAASSEN JA VERMORKEN JB WAGSTAFF J PINEDO HM
Citation: K. Hoekman et al., TUMOR-INDUCED HYPOGLYCEMIA - A CASE-REPORT, Annals of oncology, 5(3), 1994, pp. 277-281
ARGININE SUPPLEMENTATION IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS
Authors: VISSER JJ HOEKMAN K
Citation: Jj. Visser et K. Hoekman, ARGININE SUPPLEMENTATION IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS, Medical hypotheses, 43(5), 1994, pp. 339-342
Risultati: 1-25 | 26-28